<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WR9VRVQ" height="0" width="0" style="display:none;visibility:hidden">

press center

ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as the world’s largest RCO. Stay up to date on ProPharma’s latest news and most recent announcements.

Company News

July 1, 2021

Former Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, Joins NDA Partners as Expert Consultant

NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...

Company News

June 2, 2021

New Manufacturing and Import License Expands Batch Certification Services

ProPharma Group announced that its wholly-owned subsidiary ProPharma Group The Netherlands B.V., has obtained an authorization for a manufacturing and import (MIA) license. Following successful...

Company News

May 27, 2021

ProPharma Group and The Planet Group Announce Agreement to Merge

ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...

Company News

March 2, 2021

ProPharma Group Announces the Acquisition of Diamond Pharma Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...

Company News

December 15, 2020

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

Company News

September 22, 2020

Odyssey Investment Partners To Acquire ProPharma Group

Odyssey Investment Partners To Acquire ProPharma Group: Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company")...

Prev 3 4 5 6 7 Next

Inspiring the Future of Drug Development

We’ve developed a process that suits the today’s needs and a better experience for clients. Our industry is constantly changing. Let us help you accelerate your innovation.